$2.73
0.37% yesterday
Nasdaq, Aug 29, 10:00 pm CET

Codexis, Inc. Stock price

$2.73
-0.09 3.19% 1M
-0.31 10.20% 6M
-2.04 42.77% YTD
-0.17 5.86% 1Y
-4.33 61.33% 3Y
-11.07 80.22% 5Y
-1.00 26.81% 10Y
-10.53 79.41% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
+0.01 0.37%

Key metrics

Basic
Market capitalization
$245.5m
Enterprise Value
$218.6m
Net debt
positive
Cash
$66.3m
Shares outstanding
90.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.3 | 3.7
EV/Sales
3.8 | 3.3
EV/FCF
negative
P/B
4.4
Financial Health
Equity Ratio
44.9%
Return on Equity
-97.5%
ROCE
-52.2%
ROIC
-91.2%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$57.2m | $67.0m
EBITDA
$-59.3m | $-47.7m
EBIT
$-64.1m | $-56.5m
Net Income
$-65.0m | $-62.5m
Free Cash Flow
$-67.8m
Growth (TTM | estimate)
Revenue
-6.1% | 12.9%
EBITDA
-17.2% | 10.9%
EBIT
-20.8% | 3.1%
Net Income
14.9% | 4.3%
Free Cash Flow
-38.0%
Margin (TTM | estimate)
Gross
77.6%
EBITDA
-103.8% | -71.2%
EBIT
-112.2%
Net
-113.7% | -93.3%
Free Cash Flow
-118.6%
More
EPS
$-0.8
FCF per Share
$-0.8
Short interest
5.8%
Employees
188
Rev per Employee
$320.0k
Show more

Is Codexis, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Codexis, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Codexis, Inc. forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a Codexis, Inc. forecast:

Buy
77%
Hold
23%

Financial data from Codexis, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
57 57
6% 6%
100%
- Direct Costs 13 13
5% 5%
22%
44 44
7% 7%
78%
- Selling and Administrative Expenses 51 51
4% 4%
88%
- Research and Development Expense 46 46
2% 2%
81%
-59 -59
17% 17%
-104%
- Depreciation and Amortization 4.81 4.81
93% 93%
8%
EBIT (Operating Income) EBIT -64 -64
21% 21%
-112%
Net Profit -65 -65
15% 15%
-114%

In millions USD.

Don't miss a Thing! We will send you all news about Codexis, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Codexis, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 3-5, 2025, in New York, New York.
Neutral
Seeking Alpha
16 days ago
Codexis, Inc. (NASDAQ:CDXS ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Georgia L. Erbez - Chief Financial Officer Kevin Norrett - Chief Operating Officer Stephen George Dilly - President, CEO & Chairman Conference Call Participants Allison Marie Bratzel - Piper Sandler & Co., Research Division Brendan Mychal Smith - TD Cowen, Research Division Kristen Bria...
Neutral
GlobeNewsWire
16 days ago
Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators $27.3M raised via ATM facility and Innovatus loan to support expansion of ECO Synthesis REDWOOD CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enz...
More Codexis, Inc. News

Company Profile

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Head office United States
CEO Stephen Dilly
Employees 188
Founded 2002
Website www.codexis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today